Table 2. Bone morphogenic analysis by micro-computed tomography.
| Group | No. | BV (mm3) | BV/TV (%) | BS (mm2) | BS/TV (mm−1) | BS/BV (mm−1) | i.S (mm2) |
|---|---|---|---|---|---|---|---|
| PCL-TCP+hUCMSCs+PRP | 5 | 10.63±6.64 | 4.42±2.60 | 1,024.69±431.32 | 4.34±1.46 | 124.18±57.34 | 2.78±2.73 |
| PCL-TCP+PRP | 5 | 15.21±10.68 | 7.19±5.56 | 825.95±118.46 | 3.88±0.69 | 93.49±72.77 | 6.83±6.68 |
| PCL-TCP | 6 | 13.99±8.16 | 6.73±5.19 | 1,166.63±289.50 | 5.10±1.79 | 116.95±78.88 | 4.26±6.18 |
Values are presented as mean ± standard deviation.
For the reference PCL-TCP scaffold without the dental implant, TV was 255.12 mm3 and BS was 240.29 mm2.
BV: bone volume, BV/TV: bone volume fraction ratio, TV: total tissue volume, BS: regenerative new bone surface area, BS/TV: bone surface density, BS/BV: bone specific surface, i.S: interception surface, PCL-TCP: poly-(ε-caprolactone)/β-tricalcium phosphate, hUCMSC: human umbilical cord-derived mesenchymal stem cell, PRP: platelet-rich plasma.